Which Is a Better Buy: Descartes (TSX:DSG) or Kinaxis (TSX:KXS)?

The COVID-19 pandemic has created an opportunity for tech stocks. Descartes Systems (TSX:DSG)(NASDAQ:DSGX) and Kinaxis (TSX:KXS) are among the beneficiaries.

| More on:

The COVID-19 pandemic has brought tech companies in the limelight as companies and individuals are relying more on technology. Software-as-a-Service (SaaS) firms saw a sudden surge in demand, driving their stocks to new highs.

The iShares S&P/TSX Capped Information Technology Index ETF rose 25% year to date (YTD), outperforming the TSX Composite Index, which fell 4.5%.

Among software stocks, enterprise application software companies have shown resiliency toward the pandemic. As the lockdown eases, supply chain planning will become a key challenge for many companies. Moreover, the U.S.-China trade war will add regulatory complexities to supply chain management.

These challenges will become opportunities for Descartes Systems (TSX:DSG)(NASDAQ:DSGX) and Kinaxis (TSX:KXS) in the mid and long term.

Descartes and Kinaxis are in different stages of the growth cycle

Both Descartes and Kinaxis offer cloud-based and on-premise supply chain management solutions. Both earn most of their revenue from cloud subscriptions, which is recurring in nature. However, the two differ in terms of size and growth cycle.

Descartes has an annual revenue of around US$325 million and a market capitalization of $5.6 billion. Kinaxis is a smaller player with yearly revenue of around US$190 million and a market capitalization of $3.4 billion.

In a SaaS business model, a company in its early stages sees higher revenue growth and lower profit margins as it invests in customer acquisition. As the company matures, its revenue growth stabilizes, and profit margins expand as subscription fee increases with every renewal.

YoY Growth 2016 2017 2018 2019 2020
Descartes Revenue Growth 8% 10% 16% 16% 18%
Kinaxis Revenue Growth 30% 27% 15% 13% 27%
Descartes Adjusted EBITDA Growth 17% 15% 15% 16% 31%
Kinaxis Adjusted EBITDA Growth 87% -5% 41% 4% 38%

Descartes

Descartes is the fifth-largest supplier of supply chain management software in the world. It offers end-to-end logistics and supply chain operations from sourcing to procurement to custom duties and regulatory compliance to distribution. It also provides e-commerce shipping and fulfillment.

The company is in the mature stage of the growth cycle, where its growth mostly comes from acquisitions. In fiscal 2020 ended January 2020, the company earned 10% of its revenue, or US$34 million, from the acquisitions made in that year. 

Descartes’ pricing model allows customers to buy perpetual licenses, subscriptions, or use its solutions for a particular transaction. It has successfully transitioned from license software to cloud and now earns more than 87% of its revenue from subscriptions and transactions.

It has increased its revenue at a compound average annual growth rate (CAGR) of 14% between fiscal 2015 and 2020.

The company’s priority is to improve its profits. Over the last five years, its adjusted EBITDA has increased 15% and above, thereby improving its adjusted EBITDA margin from 30.4% in fiscal 2015 to 37.6% in fiscal 2020. Its profits rose faster than revenue as it enhanced its operating efficiency.

Kinaxis

Kinaxis is a smaller player, and its solutions are focused on supply chain planning. Its customers are large organizations with complex supply chain operations. It has been diversifying its customer base with no single customer accounting for more than 10% of its revenue.

The company charges both cloud and on-premise solutions a subscription fee, which is subject to renewal. The subscription fee varies depending on the size of the customer, the number of users, applications, and licensed manufacturing, distribution, and inventory sites.

Kinaxis is in the growth stage and relies heavily on new customer acquisition to increases its revenue. Around 66% of its subscription revenue growth comes from new customers. Hence, its revenue and adjusted EBITDA growth have been uneven.

Over the last five years, its revenue and adjusted EBITDA rose at a CAGR of 22% and 29%, respectively. As the company improved its operating efficiency, its adjusted EBITDA margin rose from 23% in 2014 to 30% in 2019.

Which stock delivers better returns: Descartes or Kinaxis?

Before the pandemic, the two stocks rose 55% in 2019. However, the COVID-19 pandemic skewed the returns curve toward Kinaxis, and the stock rose 68% year to date, whereas Descartes’ stock rose 16% YTD.

If you invested $1,000 each in the two shares in early 2019, you would have earned $850 from Descartes and $1,600 from Kinaxis. As both are growth stocks, Kinaxis is a better buy because of its higher returns.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Puja Tayal has no position in any of the stocks mentioned. The Motley Fool recommends KINAXIS INC.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »